Akoya Biosciences Shares Jump on 2024 Outlook, Thermo Fisher Deal
By Dean Seal
Shares of Akoya Biosciences rose after the company provided its 2024 outlook, gave preliminary fourth-quarter expectations and announced an agreement with Thermo Fisher Scientific.
The stock was up 20% at $5.20 in Monday trading. Shares traded at $9.93 a year ago.
The spatial biology company it expects full-year revenue to grow more than 20% in 2024 and for projects to achieve cash flow breakeven by the end of the year.
For the fourth quarter of 2023, the company expects revenue to be $25.5 million to $26.5 million, up from $21.2 million in the year-ago quarter and in line with analyst expectations.
Akyoya said it has signed a license and distribution agreement with Thermo Fisher allowing it to market the combination of Akoya's spatial biology solutions with the Thermo Fisher ViewRNA in situ hybridization assays for detecting protein and RNA biomarkers in tissue samples.
The agreement should facilitate a streamlined workflow for whole-slide, multiomic imaging, with protein and RNA biomarkers playing complementary roles in defining cell phenotypes and cell states, the company said.
Write to Dean Seal at dean.seal@wsj.com
(END) Dow Jones Newswires
January 08, 2024 15:42 ET (20:42 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.-
What History Tells Us About the Fed’s Next Move
-
What’s Happening In the Markets This Week
-
Alphabet’s New Dividend: What Investors Need to Know
-
Going Into Earnings, Is Palantir Stock a Buy, a Sell, or Fairly Valued?
-
Going Into Earnings, Is Eli Lilly Stock a Buy, a Sell, or Fairly Valued?
-
What’s the Difference Between the CPI and PCE Indexes?
-
5 Stocks to Buy That We Still Like After They’ve Run Up
-
Markets Brief: Stocks Are Starting to Look Cheap Again
-
AbbVie Earnings: Next-Generation Immunology Drugs Help Offset Humira Biosimilar Pressure
-
Exxon Earnings: Ignore Earnings Shortfall as Long-Term Growth and Improvement on Track
-
American Airlines Earnings: We See Costs Overshadowing Market Share This Year
-
Snap Earnings: Advertising Growth and Snapchat+ Drive Monetization
-
STMicro Earnings: We Still See an Attractive Margin of Safety Despite a Poor First-Half Forecast
-
Alphabet Shares Surge on Strong Earnings, Dividend Surprise
-
Microsoft Earnings: Firm Beats Forecasts on Strong AI and Cloud Demand
-
PG&E Earnings: Near-Term Regulatory Certainty Supports Industry-Leading Earnings Growth